Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BLRX
Stock Latest News
Company Announcements
BioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
12d ago
6K
BLRX
Premium
The Fly
BioLineRx, Hemispherian: First patient dosed in Phase 1/2a Study of GLIX1
12d ago
BLRX
Premium
The Fly
BioLineRx, Hemispherian initiate clinical trial of GLIX1
1M ago
BLRX
Premium
Ratings
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
1M ago
BLRX
Premium
Company Announcements
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
1M ago
6K
BLRX
Premium
The Fly
BioLineRx initiates Phase 1/2a study of GLIX1
1M ago
BLRX
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
2M ago
LAR
MBX
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
2M ago
AIR
CCL
Premium
Company Announcements
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
2M ago
6K
BLRX
Premium
The Fly
BioLineRx provides corporate update
2M ago
BLRX
Premium
Pre-Earnings
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
2M ago
BLRX
Premium
Company Announcements
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
3M ago
6K
BLRX
Premium
Company Announcements
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
6M ago
BLRX
Premium
Company Announcements
BioLineRx Reports Q3 2025 Results and Strategic Expansion
6M ago
BLRX
Premium
Company Announcements
BioLineRx Announces Q3 2025 Financial Results and New Joint Venture
6M ago
6K
BLRX
Premium
The Fly
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
6M ago
NVO
WRD
Premium
Market News
Options Volatility and Implied Earnings Moves Today, November 24, 2025
6M ago
A
LX
Premium
The Fly
BioLineRx reports Q3 EPS 0c vs 0c last year
6M ago
BLRX
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
6M ago
A
DE
Premium
Pre-Earnings
BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
BLRX
Premium
Company Announcements
BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1
6M ago
6K
BLRX
Premium
Company Announcements
BioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma
7M ago
6K
BLRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
